Evaluation of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Status Before and After Neoadjuvant Chemotherapy in Breast Cancer Patients
Sign Up to like & getrecommendations! Published in 2020 at "Indian Journal of Surgery"
DOI: 10.1007/s12262-020-02380-y
Abstract: Evaluation of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2/neu) receptor was carried out on 80 breast cancer patients before and after neoadjuvant chemotherapy (NAC). No differences in… read more here.
Keywords: status; receptor status; receptor progesterone; expression ... See more keywords
Estrogen receptor (ER) and progesterone receptor (PR) retest rate in breast ductal carcinoma in situ (DCIS) surgical excision specimens.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18524
Abstract: e18524Background: ER testing in breast DCIS identifies patients who benefit from endocrine manipulation. We hypothesized that ER and PR testing on both biopsy and surgical tumor specimen may increa... read more here.
Keywords: retest rate; progesterone receptor; receptor progesterone; receptor ... See more keywords